Ireland to India: Ambroxol Import Trade Route

The Ireland to India Ambroxol corridor is one of India's established pharmaceutical import routes from Ireland, with 1 shipments documented worth a combined $222 USD. The route is dominated by NEW LIFE BIOPHARMA LIMITED , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Ireland's ambroxol export sector.

Across 1 active Ireland suppliers, the average shipment value stands at $222 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with ambroxol's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 21.7%, placing it at rank #4 among India's top ambroxol import origins globally.

On the Indian buyer side, key Indian importers include KUSUM HEALTHCARE PRIVATE LIMITED . KUSUM HEALTHCARE PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $222 USD.

India's ambroxol imports from Ireland are driven primarily by a handful of large-scale Ireland manufacturers. NEW LIFE BIOPHARMA LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Ireland supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NEW LIFE BIOPHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $222 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, KUSUM HEALTHCARE PRIVATE LIMITED is the largest importer with 1 shipments worth $222 USD — representing 100% of all ambroxol imports from Ireland on this route.